Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breathing Adapted Radiotherapy for Mediastinal Lymphoma

NCT00928096 is registered in ClinicalTrials.gov with Peter Meidahl Petersen as lead sponsor.

NCT NCT00928096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00928096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breathing Adapted Radiotherapy for Mediastinal Lymphoma
Lead sponsor
Peter Meidahl Petersen
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
May 31, 2013
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma